Identification of a novel pathogenic germline KDR variant in melanoma

PURPOSE: The application of pan-cancer next generation sequencing panels in the clinical setting has facilitated the identification of low frequency somatic mutations and the testing of new therapies in solid tumors using the ‘basket trial’ scheme. However, little consideration has been given to the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Silva, Ines P., Salhi, Amel, Giles, Keith M., Vogelsang, Matjaz, Han, Sung Won, Ismaili, Naima, Lui, Kevin P., Robinson, Eric M., Wilson, Melissa, Shapiro, Richard L., Pavlick, Anna, Zhong, Judy, Kirchhoff, Tomas, Osman, Iman
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867268/
https://ncbi.nlm.nih.gov/pubmed/26631613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1811
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados